Arax Advisory Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$654K Sell
7,505
-4,710
-39% -$411K 0.03% 325
2025
Q1
$1.1M Buy
12,215
+9,815
+409% +$882K 0.07% 171
2024
Q4
$192K Buy
2,400
+980
+69% +$78.3K 0.01% 496
2024
Q3
$128K Buy
1,420
+283
+25% +$25.5K 0.01% 444
2024
Q2
$89.5K Buy
1,137
+401
+54% +$31.6K 0.01% 492
2024
Q1
$64.2K Sell
736
-8
-1% -$697 0.01% 451
2023
Q4
$61.3K Buy
744
+13
+2% +$1.07K 0.01% 436
2023
Q3
$57.3K Sell
731
-51
-7% -$4K 0.01% 438
2023
Q2
$68.9K Buy
782
+128
+20% +$11.3K 0.01% 415
2023
Q1
$52.8K Buy
654
+1
+0.2% +$81 0.01% 452
2022
Q4
$50.8K Sell
653
-28
-4% -$2.18K 0.01% 444
2022
Q3
$55K Buy
681
+95
+16% +$7.67K 0.01% 415
2022
Q2
$53K Buy
586
+1
+0.2% +$90 0.01% 416
2022
Q1
$65K Buy
585
+58
+11% +$6.44K 0.01% 414
2021
Q4
$55K Buy
527
+455
+632% +$47.5K 0.01% 444
2021
Q3
$9K Hold
72
﹤0.01% 664
2021
Q2
$9K Buy
+72
New +$9K ﹤0.01% 679
2020
Q4
$250K Buy
2,131
+38
+2% +$4.46K 0.04% 179
2020
Q3
$217K Sell
2,093
-668
-24% -$69.3K 0.04% 177
2020
Q2
$253K Sell
2,761
-320
-10% -$29.3K 0.05% 137
2020
Q1
$278K Sell
3,081
-250
-8% -$22.6K 0.06% 106
2019
Q4
$378K Sell
3,331
-244
-7% -$27.7K 0.11% 83
2019
Q3
$388K Sell
3,575
-503
-12% -$54.6K 0.12% 80
2019
Q2
$397K Buy
+4,078
New +$397K 0.13% 75
2018
Q4
$390K Sell
4,285
-226
-5% -$20.6K 0.16% 73
2018
Q3
$444K Sell
4,511
-921
-17% -$90.7K 0.18% 67
2018
Q2
$465K Buy
5,432
+1,424
+36% +$122K 0.2% 52
2018
Q1
$321K Buy
4,008
+149
+4% +$11.9K 0.17% 59
2017
Q4
$311K Buy
3,859
+34
+0.9% +$2.74K 0.13% 63
2017
Q3
$297K Buy
3,825
+488
+15% +$37.9K 0.14% 64
2017
Q2
$296K Buy
3,337
+1,035
+45% +$91.8K 0.14% 63
2017
Q1
$185K Buy
2,302
+327
+17% +$26.3K 0.09% 72
2016
Q4
$141K Buy
+1,975
New +$141K 0.07% 83